The pharmaceutical giant said it was recalling six lots of Accuretic tablets, because of the presence of nitrosamine. Due to the...

The expanded FDA approval for the GSK drug positions the immunotherapy for a broader market. On Tuesday, the FDA approved the drug, known...

Merck and Eisai add potent new weapon to the pharma battle for kidney cancer supremacy. On Wednesday, the Food and Drug Administration...